Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands
· Delayed Price · Currency is EUR
1.330
+0.040 (3.10%)
Apr 29, 2026, 3:24 PM CET
Vivoryon Therapeutics Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 38 | 42 | 52 | 212 | 249 | 380 | |
| Market Cap Growth | -13.69% | -18.93% | -75.55% | -14.71% | -34.60% | 111.35% | |
| Enterprise Value | 33 | 37 | 37 | 174 | 225 | 361 | |
| Last Close Price | 1.29 | 1.42 | 1.99 | 8.14 | 10.32 | 19.00 | |
| PS Ratio | - | - | - | -58.61 | - | 35.34 | |
| PB Ratio | 8.08 | 8.90 | 6.58 | 8.07 | 9.39 | 22.98 | |
| P/TBV Ratio | 9.72 | 10.70 | 7.40 | 8.37 | 9.56 | 23.74 | |
| EV/Sales Ratio | - | - | - | - | - | 33.52 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.17 | -1.17 | -1.18 | -1.09 | -1.00 | -0.87 | |
| Net Debt / EBITDA Ratio | 0.63 | 0.63 | 0.45 | 0.99 | 0.91 | 1.14 | |
| Net Debt / FCF Ratio | 0.66 | 0.66 | 0.48 | 1.32 | 1.21 | 1.28 | |
| Asset Turnover | - | - | - | - | - | 0.40 | |
| Quick Ratio | 6.75 | 6.75 | 6.93 | 9.30 | 9.35 | 3.57 | |
| Current Ratio | 7.68 | 7.68 | 7.20 | 9.37 | 9.40 | 4.01 | |
| Return on Equity (ROE) | -140.45% | -140.45% | -120.41% | -107.38% | -130.77% | -59.17% | |
| Return on Assets (ROA) | -59.25% | -59.25% | -62.22% | -57.95% | -65.10% | -29.48% | |
| Return on Capital Employed (ROCE) | -133.40% | -133.40% | -212.00% | -104.30% | -103.60% | -65.70% | |
| Earnings Yield | -23.17% | -21.05% | -39.65% | -13.36% | -11.32% | -3.33% | |
| FCF Yield | -22.15% | -20.12% | -36.97% | -10.16% | -8.77% | -2.96% | |
| Buyback Yield / Dilution | -2.92% | -2.92% | -3.27% | -14.64% | -10.10% | -0.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.